HIV in Europe is a multi-disciplinary platform for exchange and activities to improve early diagnosis and care of people living with HIV and Viral Hepatitis across Europe. An extensive group of experts are involved in numerous activities within the initiative. The collaborators represent civil society, policy makers, health professionals and European public health institutions.
HIV in Europe Initiative is supported by numerous organizations and companies. Financial support of the HIV in Europe initiative provided by: Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Danish National Research Foundation (grant 126), European Commission under the 3rd and 2nd Health Programmes, European Centre for Disease Prevention and Control (ECDC), Gilead Sciences, GlaxoSmithKline, Merck, Pfizer, Schering-Plough, Swedish Research Council, ViiV Healthcare and Tibotec.
If you have questions regarding the partnership, collaboration, sponsorship or any other issue, contact us by email: email@example.com
Find out more about our activities: